Expand HIND Menu
HIND MENU

HIND Latest Press Releases

-- December 8, 2025 --

Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval Business Wire 8:00 AM

-- November 25, 2025 --

Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program Business Wire 7:00 AM

-- November 18, 2025 --

Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing Business Wire 7:00 AM

-- November 4, 2025 --

Vyome Holdings Announces Results of Annual Shareholder Meeting Business Wire 9:04 AM

-- September 29, 2025 --

Vyome Holdings Acquires MIT AI Spinout Oculo Health Business Wire 7:00 AM

-- September 17, 2025 --

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity Business Wire 7:00 AM

-- September 9, 2025 --

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies Business Wire 8:30 AM

-- September 4, 2025 --

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity Business Wire 8:30 AM

-- August 21, 2025 --

Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio Business Wire 7:00 AM

-- August 18, 2025 --

Vyome Announces Strategic Review of Livechain (OTCID: LICH) Business Wire 8:30 AM

-- August 15, 2025 --

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell Business Wire 8:00 AM
Market Data Delayed 15 Minutes